Suggested Dosing
Alzheimer's Disease
100 mg PO TID
Senile Dementia & Cognitive/Memory Impairment
100 mg PO TID
ADHD in Children
200-300 mg PO qDay
Next:
Suggested Uses
Depression, mental impairment in geriatric, ADHD
Efficacy
Human trials show benefit in memory impairment, dementia
May lose its effectiveness with extended use > 16 weeks
Insufficient information for depression
Previous
Next:
Adverse Effects
Frequency Not Defined
None reported
Previous
Next:
Warnings
Contraindications
N/A
Previous
Next:
Pregnancy & Lactation
Pregnancy Category: N/A
Lactation: N/A
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Previous
Next:
Pharmacology
Metabolism: N/A
Excretion: N/A
Mechanism of Action
Major phospholipid in neuronal membranes
May increase acetylcholine release
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.